RecruitingPhase 4ACTRN12607000196448

Oxygen therapy in pneumonia

A randomised controlled trial of the effect of high flow verus titrated oxygen therapy on carbon dioxide (CO2) levels in pneumonia


Sponsor

Medical Research Institute of New Zealand

Enrollment

150 participants

Start Date

Apr 10, 2007

Study Type

Interventional

Conditions

Summary

Current standard treatment is to provide high flow oxygen to people with pneumonia. However high flow oxygen may be detrimental and few studies have looked at the use of high flow oxygen in pneumonia. An alternaitve treatment is one where the amount of oxygen received is varied depending on the oxygen level in the blood. This study compares the two treatments.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This study is for people who come to hospital with pneumonia (a lung infection). Standard treatment gives all pneumonia patients high-flow oxygen, but there is evidence this may not always be helpful and could even be harmful in some patients. This trial tests whether adjusting the amount of oxygen given based on the patient's actual blood oxygen levels (called titrated oxygen therapy) works as well as or better than the standard high-flow oxygen approach. You may be eligible if: - You are between 18 and 75 years old - You have a cough - You have at least one sign of infection such as sweating, shivering, or fever above 37.8°C - Your breathing rate is more than 18 breaths per minute You may NOT be eligible if: - You need a breathing machine (mechanical ventilation) - You have been diagnosed with COPD or emphysema - Your heart test (ECG) shows signs of a heart attack - You are suspected to have low white blood cell count with infection (neutropenic sepsis) - You have a known chronic breathing condition due to nerve or muscle disease, chest wall problems, or obesity Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients will be randomly assigned to receive oxygen regimes for 1 hour: Continuous high flow oxygen (8L/min via Hudson mask) as the intervention.

Patients will be randomly assigned to receive oxygen regimes for 1 hour: Continuous high flow oxygen (8L/min via Hudson mask) as the intervention.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000196448


Related Trials